Characterization of STK11−/−/NIC (top panel) and NIC (middle panel) by IHC confirmed DCIS (Fig. 2C) with loss of LKB1 expression, elevated expression of ErbB2, and pS6, compared to wild-type (bottom panel) mammary glands. Here, ERBB2 is linked to ductal breast carcinoma in situ.